Prescription Required
This medicine belongs to antidiabetic category
This is a combination medicine that is effective in treating Type 2 diabetes mellitus in adults
It controls blood sugar level in diabetic patients
It should be used with caution in patients with liver disease. Dose adjustment of medicine may be required. Please consult your doctor.
Consuming alcohol with it is unsafe.
Not recommended if you’re pregnant, consult your doctor for specific information.
Information not available, seek advice from your doctor.
Exercise caution when using it in individuals with kidney disease. Adjustments to the dosage may be necessary, so it's important to seek advice from your doctor.
This medicine is a combination of three antidiabetic medicines: Glibenclamide, Pioglitazone, and Metformin. These three drugs work by different mechanisms and collectively control the blood sugar level when no single or dual therapy could show any effect. Glibenclamide is a sulfonylurea which shows its activity by increasing the amount of insulin released from the pancreas and reducing the glucose level in the blood. Metformin is a biguanide, it reduces glucose production in the liver, delays glucose absorption from the intestine and makes the body sensitive to insulin. Pioglitazone is a thiazolidinedione that also increases insulin sensitivity.
Type 2 diabetes mellitus is a condition of high blood sugar level despite the production of sufficient amounts of insulin in your body. This happens because of insulin resistance, which means the cells become resistant to insulin and are not able to use it effectively. It can lead to symptoms like increased thirst, frequent urination, and fatigue.
Content Updated on
Monday, 24 June, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA